Medicine and Dentistry
Upregulation
100%
Anti-Inflammatory Drug
100%
Acetylcholinesterase Inhibitor
100%
Central Nervous System
60%
Antiinflammatory Activity
40%
Inflammatory Disorder
40%
Experimental Autoimmune Encephalomyelitis
40%
Nicotinic Receptor
40%
Alzheimer's Disease
20%
Cytokine Production
20%
Inflammatory Cytokine
20%
Multiple Sclerosis
20%
Lymphocyte Proliferation
20%
Oligodeoxynucleotide
20%
Acetylcholinesterase
20%
Myasthenia gravis
20%
Nervous System Disorder
20%
Neuroinflammation
20%
Acetylcholine
20%
Muscarinic Acetylcholine Receptor
20%
Esterase
20%
Prolymphocyte
20%
Messenger RNA
20%
Lymphocyte
20%
Diseases
20%
Keyphrases
Anti-inflammatory Properties
100%
Acetylcholinesterase Inhibitors (AChEI)
100%
Inflammatory Diseases
40%
Central Nervous System
40%
Experimental Autoimmune Encephalomyelitis
40%
Alzheimer's Disease
20%
Disease Severity
20%
Lymphocytes
20%
Acetylcholine
20%
Multiple Sclerosis
20%
Opposite Effects
20%
Esterase Activity
20%
Anti-inflammatory Activity
20%
Anti-inflammatory Effect
20%
Neurological Disorders
20%
Lymphocyte Proliferation
20%
Oligodeoxynucleotide
20%
Muscarinic Receptors
20%
Myasthenia Gravis
20%
Clinical Severity
20%
Nicotinic Acetylcholine Receptor (nAChR)
20%
Antisense
20%
Inflammatory Cytokine Response
20%
Central Nervous System Inflammation
20%
Nicotinic Receptors
20%
Acetylcholinesterase
20%
Neuroscience
Cholinergic
100%
Anti-Inflammatory
100%
Acetylcholinesterase Inhibitor
100%
Central Nervous System
60%
Experimental Autoimmune Encephalomyelitis
40%
Alzheimer's Disease
20%
Proinflammatory Cytokine
20%
Muscarinic Acetylcholine Receptor
20%
Acetylcholinesterase
20%
Acetylcholine
20%
Multiple Sclerosis
20%
Esterase
20%
Nervous System Disorder
20%
Cytokine Production
20%
Myasthenia gravis
20%
Nicotinic Acetylcholine Receptor
20%
Nicotinic Receptor
20%
Lymphocyte Proliferation
20%
Oligodeoxynucleotide
20%
Prolymphocyte
20%
Lymphocyte
20%
Messenger RNA
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cholinergic Receptor Stimulating Agent
100%
Anti-Inflammatory Drug
100%
Cholinesterase Inhibitor
100%
Inflammatory Disease
40%
Experimental Autoimmune Encephalomyelitis
40%
Nicotinic Receptor
40%
Alzheimer's Disease
20%
Muscarinic Receptor
20%
Esterase
20%
Cytokine
20%
Antiinflammatory Activity
20%
Oligodeoxynucleotide
20%
Acetylcholinesterase
20%
Multiple Sclerosis
20%
Acetylcholine
20%
Nervous System Inflammation
20%
Myasthenia gravis
20%
Messenger RNA
20%
Diseases
20%